| Literature DB >> 33447583 |
Francesco Ziglioli1, Umberto Maestroni1, Carmelinda Manna2, Giulio Negrini2, Giorgia Granelli1, Valentina Greco2, Francesco Pagnini2, Massimo De Filippo2.
Abstract
The growing interest in multiparametric MRI is leading to important changes in the diagnostic process of prostate cancer. MRI-targeted biopsy is likely to become a standard for the diagnosis of prostate cancer in the next years. Despite it is well known that MRI has no role as a staging technique, it is clear that multiparametric MRI may be of help in active surveillance protocols. Noteworthy, MRI in active surveillance is not recommended, but a proper understanding of its potential may be of help in achieving the goals of a delayed treatment strategy. Moreover, the development of minimally invasive techniques, like laparoscopic and robotic surgery, has led to greater expectations as regard to the functional outcomes of radical prostatectomy. Multiparametric MRI may play a role in planning surgical strategies, with the aim to provide the highest oncologic outcome with a minimal impact on the quality of life. We maintain that a proper anatomic knowledge of prostate lesions may allow the surgeon to achieve a better result in planning as well as in performing surgery and help the surgeon and the patient engage in a shared decision in planning a more effective strategy for prostate cancer control and treatment. This review highlights the advantages and the limitations of multiparametric MRI in prostate cancer diagnosis, in active surveillance and in planning surgery. 2020 Gland Surgery. All rights reserved.Entities:
Keywords: Multiparametric MRI; active surveillance; extraprostatic extension; prostate cancer; tageted biopsy
Year: 2020 PMID: 33447583 PMCID: PMC7804524 DOI: 10.21037/gs-20-561
Source DB: PubMed Journal: Gland Surg ISSN: 2227-684X